Close
MIDAS
MIDAS Network Member

Paper Information

Title

A Review of Primary Cutaneous CD30(+) Lymphoproliferative Disorders.

Abstract

 LPDs have a favorable prognosis, secondary malignancies should be considered as part of the initial evaluation, and patients should have ongoing surveillance.

Journal

Hematology/oncology clinics of North America

Citation

Chen C, Gu YD, Geskin LJ. (2019). A Review of Primary Cutaneous CD30(+) Lymphoproliferative Disorders. Hematology/oncology clinics of North America, 33(1)

MIDAS Authors